Statistics
Publications
3
Citations
68
H-Index
3
Active since
2019
Affiliations
Bidyadhar Sethy is an author at Taipei Medical University specializing in drug discovery, medicinal chemistry, and antiviral pharmacology.
Publications per year
2019–2024
3
3
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Bidyadhar Sethy, Richa Upadhyay, Iin Narwanti et al. · APOPTOSIS · 2024 · 10 citations · Full text
1–3 of 3